Adocia Competitors and Similar CompaniesClear all
Adocia's competitors and similar companies include Lion TCR, European Medical Solutions, Vericel and Citryll.
 Adocia Adocia is a clinical-stage biotechnology company that specializes in the research and development of innovative formulations of already-approved therapeutic proteins. |  Lion TCR Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases. |  European Medical Solutions European Medical Solutions (formerly known as ASIT Biotech) is a clinical-stage biopharmaceutical company that focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies. |  Vericel Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. |  Citryll Citryll is a pharmaceutical company engaged in the treatment of autoimmune and some other human diseases with the help of tACPA program | |
Founding Date | Founding Date 2005 | Founding Date N/A | Founding Date 1997 | Founding Date 1989 | Founding Date 2019 |
Type | Type Public | Type Private | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Lyon-3E-Arrondissement, FR HQ | Locations Singapore, SG HQ Guangzhou, CN Singapore, SG Singapore, SG | Locations Liège, BE HQ Sint Lambrechts Woluwe, BE | Locations Cambridge, US HQ Ann Arbor, US | Locations Oss, NL HQ |
Employees | Employees 75 | Employees N/A | Employees 2630% increase | Employees 24112% increase | Employees 313% increase |
Valuation ($) | Valuation ($) 158 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €9.3m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) €49.9m (FY, 2025) | Revenue (est.) $276.3m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €1.1m (FY, 2024) | Cost of goods N/A | Cost of goods €33.5m (FY, 2025) | Cost of goods $70.7m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €11m (FY, 2024) | Gross profit N/A | Gross profit €17.5m (FY, 2025) | Gross profit $205.6m (FY, 2025) | Gross profit N/A |
Net income | Net income (€9.3m) (FY, 2024) | Net income N/A | Net income €1.8m (FY, 2025) | Net income $16.5m (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 20m (about 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 23m (almost 6 years ago) |
Total funding raised | Total funding raised $ 37m | Total funding raised $ 20m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 39.9m |
For sources of this data, please see the company profile
View Company Profiles
Lion TCR
HQ
Singapore, SG
Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.
View companyEuropean Medical Solutions
HQ
Liège, BE
European Medical Solutions (formerly known as ASIT Biotech) is a clinical-stage biopharmaceutical company that focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies.
View companyVericel
HQ
Cambridge, US
Employees
241↑ 12% increase
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions.
View companyCitryll
HQ
Oss, NL
Employees
31↑ 3% increase
Citryll is a pharmaceutical company engaged in the treatment of autoimmune and some other human diseases with the help of tACPA program
View company